Aktienanalyse zu ICU Medical Inc (ICUI)ICUIICU Medical Inc

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

ICU Medical is a good buy right now due to its current price of $175.10, which is below the analyst price targets of $200, indicating a potential upside of 14.2%. Additionally, the company reported a gross margin of 42.61% in Q2 2026, showcasing strong operational efficiency. The main risk is the current RSI of 29.191, which indicates that the stock is oversold and may face further downward pressure in the short term.

5 analysts cover ICUI: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 173.50.